High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis
This randomized clinical trial examines the efficacy of high-dose cholecalciferol (vitamin D) as monotherapy in reducing disease activity in patients with clinically isolated syndrome typical of multiple sclerosis.